Previous 10 | Next 10 |
2023-11-21 11:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 20, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, S.V.P. of Corporate Communications, will participate in an Analyst-Moderated fireside chat at the Piper Sandler 35 th Annual Healthcare C...
2023-11-17 15:03:18 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Call Transcript Amphastar Pharmaceuticals: Great Growth At A High Price Amphastar: Dip, But No Slip, Rebound Playbook (Rating Upgrade) Amphastar P...
2023-11-15 17:36:04 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals: Great Growth At A High Price Amphastar: Dip, But No Slip, Rebound Playbook (Rating Upgrade) Amphastar Pharmaceuticals Q3 2023 Earnings Preview Amphastar Pharmaceuticals prices...
2023-11-08 22:39:05 ET Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Conference Call November 08, 2023, 05:00 PM ET Company Participants Dan Dischner - SVP of Corporate Communications Bill Peters - CFO Conference Call Participants Glen Santangel...
2023-11-08 17:22:15 ET Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q3 Non-GAAP EPS of $1.15 beats by $0.46 . Revenue of $180.6M (+50.3% Y/Y) beats by $6.8M . For further details see: Amphastar Pharmaceuticals Non-GAAP EPS of $1.15 beats by $...
Reports Net Revenues of $180.6 Million for the Three Months Ended September 30, 2023 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2023. Th...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
Amphastar Pharmaceuticals Inc. (AMPH) is expected to report $0.67 for Q3 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2023 ended September 30, 2023, after the market closes on Wednesday, November 8, 2023, and will hold a conference call to ...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...